How should I evaluate and manage an 88-year-old woman with leg and foot cramping that worsens at bedtime and improves with walking, consistent with restless‑leg syndrome?

Evaluation and Management of Restless Legs Syndrome in an 88-Year-Old Woman

Check serum ferritin immediately and start oral ferrous sulfate if ferritin is <50 ng/mL, as iron deficiency is a treatable cause of RLS that can improve symptoms without the risks of dopaminergic medications in elderly patients. 1, 2

Diagnostic Confirmation

Your patient's presentation is classic for restless legs syndrome (RLS). The key diagnostic features are all present 2:

• Urge to move legs with uncomfortable cramping sensations
• Worsens at rest/bedtime (inactivity triggers symptoms)
• Improves with walking (movement provides relief)
• Circadian pattern (worse in evening/night)

The physical examination will likely be unremarkable in primary RLS, but perform a thorough neurologic exam to exclude secondary causes like peripheral neuropathy, radiculopathy, or vascular disease (intermittent claudication would worsen with walking, not improve) 2.

Essential Laboratory Testing

Obtain serum ferritin and transferrin saturation immediately. Iron deficiency plays a critical role in RLS pathophysiology through impaired dopamine transport in the substantia nigra 2. Ferritin <50 ng/mL is consistent with RLS and mandates iron supplementation 2.

Review her medication list for RLS-exacerbating drugs: tricyclic antidepressants, SSRIs, lithium, and antipsychotics 2.

Treatment Algorithm

First-Line: Iron Supplementation (if indicated)

If ferritin <50 ng/mL, start ferrous sulfate 1. This is particularly important in your 88-year-old patient as it avoids the significant risks of dopaminergic medications in the elderly (orthostatic hypotension, falls, confusion, compulsive behaviors) 2.

Second-Line: Pharmacologic Options

The 2025 AASM guidelines represent a major shift away from dopamine agonists as standard first-line therapy 1. This is critical for your elderly patient:

Preferred options:

• Gabapentin or pregabalin (α2δ ligands) - now favored over dopamine agonists 1
• Extended-release oxycodone or other opioids - conditional recommendation 1

Avoid as standard therapy (due to augmentation risk):

• Pramipexole, ropinirole, rotigotine, levodopa - the 2025 guidelines now suggest against standard use of these dopamine agonists 1. While they may provide short-term symptom relief, long-term use commonly causes augmentation (paradoxical worsening with earlier symptom onset, increased intensity, and spread to other body parts) 1, 2.

Critical Consideration for Your 88-Year-Old Patient

In elderly patients, dopamine agonists carry substantial risks: nausea, orthostatic hypotension (fall risk), sleepiness, headache, and compulsive behaviors 2. The 2009 geriatric guidelines emphasized these concerns, and the 2025 AASM guidelines have now downgraded dopamine agonists due to augmentation problems 1, 2.

If dopaminergic therapy were considered despite these concerns (only if patient values short-term symptom relief over long-term adverse effects), start with the lowest possible dose: ropinirole 0.25 mg or pramipexole 0.125 mg, 1-3 hours before bedtime 2. However, this is no longer recommended as standard practice 1.

Non-Pharmacologic Interventions

Implement immediately alongside any pharmacologic therapy 2:

• Moderate exercise (not close to bedtime)
• Eliminate caffeine completely
• Avoid alcohol
• Smoking cessation if applicable
• Consider massage or temperate baths for symptom relief

Common Pitfalls to Avoid

1. Don't miss iron deficiency - this is the most reversible cause and should always be checked and corrected first 2

2. Don't start dopamine agonists without discussing augmentation risk - this complication is common with long-term use and can make symptoms worse than baseline 1, 2

3. Don't confuse with peripheral vascular disease - claudication worsens with walking; RLS improves with walking 2

4. Don't overlook medication-induced RLS - review and discontinue offending agents if possible 2

5. In elderly patients, prioritize fall prevention - avoid medications causing orthostatic hypotension or sedation 2

Monitoring and Follow-up

Recheck ferritin if symptoms worsen or if augmentation develops on dopaminergic therapy 1. If initial treatment fails, consider referral to neurology or sleep medicine for advanced management options including IV iron formulations (ferric carboxymaltose has strong recommendation for appropriate iron status) 1.